Laurion Capital Management LP grew its position in CME Group Inc (NASDAQ:CME) by 50.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 45,005 shares of the financial services provider’s stock after purchasing an additional 15,000 shares during the period. Laurion Capital Management LP’s holdings in CME Group were worth $7,407,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Sheaff Brock Investment Advisors LLC boosted its position in shares of CME Group by 0.3% during the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock worth $4,146,000 after purchasing an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC boosted its position in shares of CME Group by 1.4% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock worth $860,000 after purchasing an additional 65 shares during the period. Dubuque Bank & Trust Co. boosted its position in shares of CME Group by 83.1% during the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares during the period. Front Barnett Associates LLC boosted its position in shares of CME Group by 5.4% during the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock worth $267,000 after purchasing an additional 73 shares during the period. Finally, Ascension Asset Management LLC boosted its position in shares of CME Group by 0.6% during the 4th quarter. Ascension Asset Management LLC now owns 12,385 shares of the financial services provider’s stock worth $2,330,000 after purchasing an additional 75 shares during the period. 84.78% of the stock is owned by institutional investors and hedge funds.

In other news, insider Kathleen M. Cronin sold 8,340 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total value of $1,397,283.60. Following the sale, the insider now directly owns 41,604 shares in the company, valued at approximately $6,970,334.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of the firm’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the completion of the sale, the director now owns 42,004 shares in the company, valued at $7,474,191.76. The disclosure for this sale can be found here. Insiders sold a total of 38,489 shares of company stock valued at $6,739,196 in the last three months. 1.20% of the stock is currently owned by corporate insiders.

A number of equities analysts recently weighed in on CME shares. Bank of America set a $180.00 price objective on shares of CME Group and gave the stock a “hold” rating in a research report on Tuesday, April 9th. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 8th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $210.00 price objective on shares of CME Group in a research report on Friday, February 15th. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, April 9th. Finally, BidaskClub cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Friday, March 22nd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the stock. CME Group has an average rating of “Hold” and a consensus target price of $189.71.

Shares of CME stock opened at $183.85 on Monday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. CME Group Inc has a 52 week low of $157.21 and a 52 week high of $197.08. The company has a market capitalization of $65.64 billion, a price-to-earnings ratio of 26.96, a price-to-earnings-growth ratio of 4.21 and a beta of 0.32.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The company had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter last year, the company posted $1.86 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc will post 6.62 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a $0.75 dividend. The ex-dividend date is Friday, June 7th. This represents a $3.00 annualized dividend and a yield of 1.63%. CME Group’s dividend payout ratio is presently 43.99%.

ILLEGAL ACTIVITY NOTICE: “Laurion Capital Management LP Has $7.41 Million Stake in CME Group Inc (CME)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dailypolitical.com/2019/05/20/laurion-capital-management-lp-has-7-41-million-stake-in-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Different Types of Derivatives

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.